Gastrointestinal carcinoid tumors start from cells of the diffuse neuroendocrine system (scattered throughout the GI system) of cells that help control the release of digestive juices, the speed of food movement through the digestive system, and the growth of other types of GI cells. The most common location of carcinoid tumors is in the appendix and small intestine, with other sites including the rectum, colon, and stomach. In the pancreas, these cancers are known as islet cell tumors. According to the American Cancer Society, there are thought to be 11,000 to 12,000 neuroendocrine tumors, with two out of every three of these occurring in the gastrointestinal system.
Diagnosis is made with blood and urine tests, physical exam and a medical history.
Our patients with gastrointestinal carcinoid tumors are treated at the Moores Gastrointestinal Cancer Unit. See the Gastrointestinal Cancer Unit for more information.
You can also review the tabs at top of this page for information on gastrointestinal carcinoid tumor symptoms, risks, and treatment.